在混杂的美国人群中,COVID-19住院治疗的新风险位置
Silvia Diz-de Almeida1,2,3,4, Raquel Cruz1,2,3,4, Andre D Luchessi5
1ERN-ITHACA-European Reference Network, Soria, Spain.
eLife
|October 3, 2024
概括
这项研究在混合美国人中确定了严重的COVID-19住院治疗的新型遗传风险位点. 它强调了在遗传研究中多样化的种群对于发现特定种群的风险因素的重要性.
科学领域:
- 遗传学 遗传学 是一个
- 基因组学就是基因组学.
- 流行病学 流行病学
背景情况:
- 对严重的COVID-19的遗传研究已经确定了共同的风险因素,但由于非欧洲人口的代表性不足而受到限制.
- 发现特定人群的遗传风险位点对于理解疾病异质性至关重要.
- 以前的研究还没有完全捕捉到混合人群中COVID-19住院治疗的遗传结构.
研究的目的:
- 进行一项全基因组关联研究 (GWAS) 针对COVID-19在混合美国人的住院治疗.
- 为了确定新的基因风险位点,特定于或跨多种人群共享.
- 评估不同祖先的多基因风险评分的有用性.
主要方法:
- 全基因组关联研究 (GWAS) 在4702名住院的COVID-19病例中进行.
- 包括来自SCOURGE联盟和COVID-19宿主遗传倡议的数据.
- 跨民族元分析和多基因风险评分评估.
主要成果:
- 鉴定了四个全基因组显著的协会,用于COVID-19住院治疗.
- 在拉丁美洲人群中发现了两个新的风险位点 (BAZ2B和DDIAS).
- 在CREBBP中通过跨种族元分析识别了一个新的跨人口风险位置.
- 在混杂的美国队列中对交叉祖先多基因风险评分表现的评估.
结论:
- 这项研究代表了迄今为止在混合拉丁美洲的COVID-19住院治疗中最大的GWAS.
- 在混合种群中发现了严重COVID-19的新遗传风险位点.
- 强调在基因组研究中包括多样化的种群的关键需要,以发现特定于种群的遗传因素.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Confounding in Epidemiological Studies
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...


